{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:14:31Z","timestamp":1792642471233,"version":"4.5.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["UMO-2015\/17\/B\/NZ7\/02937"],"award-info":[{"award-number":["UMO-2015\/17\/B\/NZ7\/02937"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10787-017-0405-5","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T10:26:19Z","timestamp":1508927179000},"page":"361-374","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Evaluation of cebranopadol, a dually acting nociceptin\/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain"],"prefix":"10.1007","volume":"26","author":[{"given":"Kinga","family":"Sa\u0142at","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Furga\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sa\u0142at","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,25]]},"reference":[{"issue":"10","key":"405_CR1","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1185\/03007995.2011.614934","volume":"27","author":"C Argoff","year":"2011","unstructured":"Argoff C (2011) Mechanisms of pain transmission and pharmacologic management. Curr Med Res Opin 27(10):2019\u20132031. doi: 10.1185\/03007995.2011.614934","journal-title":"Curr Med Res Opin"},{"key":"405_CR2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2147\/VHRM.S5255","volume":"6","author":"M Baumh\u00e4kel","year":"2010","unstructured":"Baumh\u00e4kel M, B\u00f6hm M (2010) Recent achievements in the management of Raynaud\u2019s phenomenon. Vasc Health Risk Manag 6:207\u2013214","journal-title":"Vasc Health Risk Manag"},{"key":"405_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.fct.2015.02.016","volume":"80","author":"S Bhalla","year":"2015","unstructured":"Bhalla S, Singh N, Jaggi AS (2015) Dose-related neuropathic and anti-neuropathic effects of simvastatin in vincristine-induced neuropathic pain in rats. Food Chem Toxicol 80:32\u201340. doi: 10.1016\/j.fct.2015.02.016","journal-title":"Food Chem Toxicol"},{"key":"405_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/SPC.0000000000000129","volume":"9","author":"MF Bird","year":"2015","unstructured":"Bird MF, Lambert DG (2015) Simultaneous targeting of multiple opioid receptor types. Curr Opin Support Palliat Care 9:98\u2013102. doi: 10.1097\/SPC.0000000000000129","journal-title":"Curr Opin Support Palliat Care"},{"issue":"2","key":"405_CR5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1536\/jhj.44.243","volume":"44","author":"MT Bombig","year":"2003","unstructured":"Bombig MT, Ferreira C, Mora O et al (2003) Pravastatin protection from cold stress in myocardium of rats. Jpn Heart J 44(2):243\u2013255","journal-title":"Jpn Heart J"},{"key":"405_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0014-2999(02)01833-2","volume":"447","author":"L Briscini","year":"2002","unstructured":"Briscini L, Corradini L, Ongini E, Bertorelli R (2002) Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury. Eur J Pharmacol 447:59\u201365. doi: 10.1016\/S0014-2999(02)01833-2","journal-title":"Eur J Pharmacol"},{"key":"405_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1529-8027.2006.0093.x","volume":"11","author":"Y Chen","year":"2006","unstructured":"Chen Y, Sommer C (2006) Nociceptin and its receptor in rat dorsal root ganglion neurons in neuropathic and inflammatory pain models: implications on pain processing. J Peripher Nerv Syst 11:232\u2013240. doi: 10.1111\/j.1529-8027.2006.0093.x","journal-title":"J Peripher Nerv Syst"},{"key":"405_CR8","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.jpain.2013.05.011","volume":"14","author":"XY Chen","year":"2013","unstructured":"Chen XY, Li K, Light AR, Fu KY (2013) Simvastatin attenuates formalin-induced nociceptive behaviors by inhibiting microglial RhoA and p38 MAPK activation. J Pain 14:1310\u20131319. doi: 10.1016\/j.jpain.2013.05.011","journal-title":"J Pain"},{"key":"405_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0014-2999(00)00505-7","volume":"402","author":"MR Corboz","year":"2000","unstructured":"Corboz MR, Rivelli MA, Egan RW et al (2000) Nociceptin inhibits capsaicin-induced bronchoconstriction in isolated guinea pig lung. Eur J Pharmacol 402:171\u2013179. doi: 10.1016\/S0014-2999(00)00505-7","journal-title":"Eur J Pharmacol"},{"key":"405_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0006-8993(01)02520-3","volume":"905","author":"L Corradini","year":"2001","unstructured":"Corradini L, Briscini L, Ongini E, Bertorelli R (2001) The putative OP4 antagonist, [Nphe1]nociceptin(1-13)NH2, prevents the effects of nociceptin in neuropathic rats. Brain Res 905:127\u2013133. doi: 10.1016\/S0006-8993(01)02520-3","journal-title":"Brain Res"},{"key":"405_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.pain.2004.03.037","volume":"110","author":"C Courteix","year":"2004","unstructured":"Courteix C, Coudor\u00e9-Civiale MA, Privat AM et al (2004) Evidence for an exclusive antinociceptive effect of nociceptin\/orphanin FQ, an endogenous ligand for the ORL1 receptor, in two animal models of neuropathic pain. Pain 110:236\u2013245. doi: 10.1016\/j.pain.2004.03.037","journal-title":"Pain"},{"key":"405_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.pharep.2015.12.007","volume":"68","author":"A Czopek","year":"2016","unstructured":"Czopek A, Sa\u0142at K, Byrtus H et al (2016) Antinociceptive activity of novel amide derivatives of imidazolidine-2,4-dione in a mouse model of acute pain. Pharmacol Rep 68:529\u2013535. doi: 10.1016\/j.pharep.2015.12.007","journal-title":"Pharmacol Rep"},{"key":"405_CR13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1165\/rcmb.2008-0488OC","volume":"42","author":"B D\u2019Agostino","year":"2010","unstructured":"D\u2019Agostino B, Orlotti D, Cal\u00f2 G et al (2010) Nociceptin modulates bronchoconstriction induced by sensory nerve activation in mouse lung. Am J Respir Cell Mol Biol 42:250\u2013254. doi: 10.1165\/rcmb.2008-0488OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"405_CR14","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1111\/j.1365-2826.2012.02361.x","volume":"24","author":"G Delaney","year":"2012","unstructured":"Delaney G, Dawe KL, Hogan R et al (2012) Role of nociceptin\/orphanin FQ and NOP receptors in the response to acute and repeated restraint stress in rats. J Neuroendocrinol 24:1527\u20131541. doi: 10.1111\/j.1365-2826.2012.02361.x","journal-title":"J Neuroendocrinol"},{"key":"405_CR15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0022-3565(25)05180-8","volume":"107","author":"NB Eddy","year":"1953","unstructured":"Eddy NB, Leimbach D (1953) Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. J Pharmacol Exp Ther 107:385\u2013393","journal-title":"J Pharmacol Exp Ther"},{"key":"405_CR16","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1097\/00001756-199705260-00034","volume":"8","author":"K Erb","year":"1997","unstructured":"Erb K, Liebel JT, Tegeder I et al (1997) Spinally delivered nociceptin\/orphanin FQ reduces flinching behaviour in the rat formalin test. NeuroReport 8:1967\u20131970","journal-title":"NeuroReport"},{"key":"405_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","volume":"14","author":"NB Finnerup","year":"2015","unstructured":"Finnerup NB, Attal N, Haroutounian S et al (2015) Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 14:162\u2013173. doi: 10.1016\/S1474-4422(14)70251-0","journal-title":"Lancet Neurol"},{"issue":"2","key":"405_CR18","first-page":"8","volume":"39","author":"NM Gades","year":"2000","unstructured":"Gades NM, Danneman PJ, Wixson SK, Tolley EA (2000) The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice. Contemp Top Lab Anim Sci 39(2):8\u201313","journal-title":"Contemp Top Lab Anim Sci"},{"key":"405_CR19","doi-asserted-by":"publisher","first-page":"836569","DOI":"10.4061\/2011\/836569","volume":"2011","author":"EC Gavioli","year":"2011","unstructured":"Gavioli EC, Rom\u00e3o PRT (2011) NOP receptor ligands as potential agents for inflammatory and autoimmune diseases. J Amino Acids 2011:836569. doi: 10.4061\/2011\/836569","journal-title":"J Amino Acids"},{"key":"405_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/bs.vh.2014.11.003","volume":"97","author":"EC Gavioli","year":"2015","unstructured":"Gavioli EC, de Medeiros IU, Monteiro MC et al (2015) Nociceptin\/orphanin FQ-NOP receptor system in inflammatory and immune-mediated diseases. Vitam Horm 97:241\u2013266. doi: 10.1016\/bs.vh.2014.11.003","journal-title":"Vitam Horm"},{"key":"405_CR21","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0196-9781(00)00237-0","volume":"21","author":"S Giuliani","year":"2000","unstructured":"Giuliani S, Lecci A, Maggi CA (2000) Nociceptin and neurotransmitter release in the periphery. Peptides 21:977\u2013984. doi: 10.1016\/S0196-9781(00)00237-0","journal-title":"Peptides"},{"key":"405_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13809","author":"T G\u00fcnther","year":"2017","unstructured":"G\u00fcnther T, Dasgupta P, Mann A et al (2017) Targeting multiple opioid receptors\u2014improved analgesics with reduced side effects? Br J Pharmacol. doi: 10.1111\/bph.13809","journal-title":"Br J Pharmacol"},{"key":"405_CR23","doi-asserted-by":"crossref","unstructured":"Hao S, Ogawa H (1998) Naltrexone, but not atropine or yohimbine, antagonizes suppression of formalin-induced spinal sensitization by intrathecal nociceptin. Life Sci 63:PL 167\u201373","DOI":"10.1016\/S0024-3205(98)00359-2"},{"key":"405_CR24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0304-3959(98)00071-2","volume":"76","author":"J-X Hao","year":"1998","unstructured":"Hao J-X, Xu IS, Wiesenfeld-Hallin Z, Xu X-J (1998) Anti-hyperalgesic and anti-allodynic effects of intrathecal nociceptin\/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation. Pain 76:385\u2013393. doi: 10.1016\/S0304-3959(98)00071-2","journal-title":"Pain"},{"key":"405_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0304-3959(87)90088-1","volume":"30","author":"S Hunskaar","year":"1987","unstructured":"Hunskaar S, Hole K (1987) The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30:103\u2013114. doi: 10.1016\/0304-3959(87)90088-1","journal-title":"Pain"},{"key":"405_CR26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0022-3565(24)35102-X","volume":"291","author":"M Inoue","year":"1999","unstructured":"Inoue M, Shimohira I, Yoshida A et al (1999) Dose-related opposite modulation by nociceptin\/orphanin FQ of substance P nociception in the nociceptors and spinal cord. J Pharmacol Exp Ther 291:308\u2013313","journal-title":"J Pharmacol Exp Ther"},{"issue":"2\u20133","key":"405_CR27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.tox.2006.11.073","volume":"230","author":"S I\u015feri","year":"2007","unstructured":"I\u015feri S, Ercan F, Gedik N, Y\u00fcksel M, Alican I (2007) Simvastatin attenuates cisplatin-induced kidney and liver damage in rats. Toxicology 230(2\u20133):256\u2013264","journal-title":"Toxicology"},{"key":"405_CR28","doi-asserted-by":"publisher","first-page":"475","DOI":"10.4103\/0253-7613.99311","volume":"44","author":"SR Jaiswal","year":"2012","unstructured":"Jaiswal SR, Sontakke SD (2012) Experimental evaluation of analgesic and anti-inflammatory activity of simvastatin and atorvastatin. Indian J Pharmacol 44:475\u2013479. doi: 10.4103\/0253-7613.99311","journal-title":"Indian J Pharmacol"},{"key":"405_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neulet.2013.03.026","volume":"542","author":"J Ju","year":"2013","unstructured":"Ju J, Shin DJ, Na YC, Yoon MH (2013) Role of spinal opioid receptor on the antiallodynic effect of intrathecal nociceptin in neuropathic rat. Neurosci Lett 542:118\u2013122. doi: 10.1016\/j.neulet.2013.03.026","journal-title":"Neurosci Lett"},{"key":"405_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0014-2999(99)00112-0","volume":"370","author":"J Kamei","year":"1999","unstructured":"Kamei J, Ohsawa M, Kashiwazaki T, Nagase H (1999) Antinociceptive effects of the ORL1 receptor agonist nociceptin\/orphanin FQ in diabetic mice. Eur J Pharmacol 370:109\u2013116. doi: 10.1016\/S0014-2999(99)00112-0","journal-title":"Eur J Pharmacol"},{"key":"405_CR31","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1124\/jpet.111.184663","volume":"339","author":"TV Khroyan","year":"2011","unstructured":"Khroyan TV, Polgar WE, Orduna J et al (2011) Differential effects of NOP receptor agonists in acute versus chronic pain: studies with bifunctional NOP\/mu receptor agonists in the sciatic nerve ligation chronic pain model in mice. J Pharmacol Exp Ther 339:687\u2013693. doi: 10.1124\/jpet.111.184663","journal-title":"J Pharmacol Exp Ther"},{"key":"405_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0304-3940(97)13414-0","volume":"223","author":"MA King","year":"1997","unstructured":"King MA, Rossi GC, Chang AH et al (1997) Spinal analgesic activity of orphanin FQ\/nociceptin and its fragments. Neurosci Lett 223:113\u2013116. doi: 10.1016\/S0304-3940(97)13414-0","journal-title":"Neurosci Lett"},{"issue":"9","key":"405_CR33","doi-asserted-by":"publisher","first-page":"e25894","DOI":"10.1371\/journal.pone.0025894","volume":"6","author":"WM Knowlton","year":"2011","unstructured":"Knowlton WM, Daniels RL, Palkar R, McCoy DD, McKemy DD (2011) Pharmacological blockade of TRPM8 ion channels alters cold and cold pain responses in mice. PLoS One 6(9):e25894. doi: 10.1371\/journal.pone.0025894","journal-title":"PLoS One"},{"issue":"1","key":"405_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/brb3.34","volume":"2","author":"T Kono","year":"2012","unstructured":"Kono T, Satomi M, Suno M et al (2012) Oxaliplatin induced neurotoxicity involves TRPM8 in the mechanism of acute hypersensitivity to cold sensation. Brain Behav 2(1):68\u201373. doi: 10.1002\/brb3.34","journal-title":"Brain Behav"},{"key":"405_CR35","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/bja\/aeu332","volume":"114","author":"DG Lambert","year":"2015","unstructured":"Lambert DG, Bird MF, Rowbotham DJ (2015) Cebranopadol: a first in-class example of a nociceptin\/orphanin FQ receptor and opioid receptor agonist. Br J Anaesth 114:364\u2013366. doi: 10.1093\/bja\/aeu332","journal-title":"Br J Anaesth"},{"key":"405_CR36","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/j.neuroscience.2006.05.036","volume":"141","author":"JD Leggett","year":"2006","unstructured":"Leggett JD, Harbuz MS, Jessop DS, Fulford AJ (2006) The nociceptin receptor antagonist [Nphe1, Arg14, Lys15]nociceptin\/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin\/orphanin FQ on the HPA axis in rats. Neuroscience 141:2051\u20132057. doi: 10.1016\/j.neuroscience.2006.05.036","journal-title":"Neuroscience"},{"issue":"1","key":"405_CR37","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000456111","volume":"41","author":"J Liang","year":"2017","unstructured":"Liang J, Yin K, Cao X et al (2017) Attenuation of low ambient temperature-induced myocardial hypertrophy by atorvastatin via promoting Bcl-2 expression. Cell Physiol Biochem 41(1):286\u2013295. doi: 10.1159\/000456111","journal-title":"Cell Physiol Biochem"},{"key":"405_CR01","unstructured":"Linz K, Christoph T, Schiene K, Koch T, Englberger W (2013) GRT-TA2210, a selective NOP receptor agonist, is active in mouse models of inflammatory and neuropathic pain. In: EFIC\u20138th \u201cPain in Europe\u201d Congress, 2013 October 9\u201312, Florence, Italy. Abstract 599"},{"key":"405_CR38","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1124\/jpet.114.213694","volume":"349","author":"K Linz","year":"2014","unstructured":"Linz K, Christoph T, Tzschentke TM et al (2014) Cebranopadol: a novel potent analgesic nociceptin\/orphanin FQ peptide and opioid receptor agonist. J Pharmacol Exp Ther 349:535\u2013548. doi: 10.1124\/jpet.114.213694","journal-title":"J Pharmacol Exp Ther"},{"key":"405_CR39","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/ALN.0000000000001530","volume":"126","author":"K Linz","year":"2017","unstructured":"Linz K, Schr\u00f6der W, Frosch S, Christoph T (2017) Opioid-type respiratory depressant side effects of cebranopadol in rats are limited by its nociceptin\/orphanin FQ Peptide receptor agonist activity. Anesthesiology 126:708\u2013715. doi: 10.1097\/ALN.0000000000001530","journal-title":"Anesthesiology"},{"key":"405_CR40","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/B978-0-444-52902-2.00042-4","volume":"115","author":"H Manji","year":"2013","unstructured":"Manji H (2013) Drug-induced neuropathies. Handb Clin Neurol 115:729\u2013742. doi: 10.1016\/B978-0-444-52902-2.00042-4","journal-title":"Handb Clin Neurol"},{"key":"405_CR41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.pbb.2015.08.002","volume":"137","author":"MT Mansouri","year":"2015","unstructured":"Mansouri MT, Khodayar MJ, Tabatabaee A, Ghorbanzadeh B, Naghizadeh B (2015) Modulation of morphine antinociceptive tolerance and physical dependence by co-administration of simvastatin. Pharmacol Biochem Behav 137:38\u201343. doi: 10.1016\/j.pbb.2015.08.002","journal-title":"Pharmacol Biochem Behav"},{"key":"405_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.24008","author":"MT Mansouri","year":"2017","unstructured":"Mansouri MT, Naghizadeh B, Ghorbanzadeh B, Alboghobeish S (2017) Systemic and local anti-nociceptive effects of simvastatin in the rat formalin assay: role of peroxisome proliferator-activated receptor \u03b3 and nitric oxide. J Neurosci Res. doi: 10.1002\/jnr.24008","journal-title":"J Neurosci Res"},{"key":"405_CR43","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10787-016-0288-x","volume":"24","author":"L Marwaha","year":"2016","unstructured":"Marwaha L, Bansal Y, Singh R et al (2016) TRP channels: potential drug target for neuropathic pain. Inflammopharmacology 24:305\u2013317","journal-title":"Inflammopharmacology"},{"key":"405_CR44","doi-asserted-by":"publisher","first-page":"e66830","DOI":"10.1371\/journal.pone.0066830","volume":"8","author":"F Massicot","year":"2013","unstructured":"Massicot F, Hache G, David L et al (2013) P2X7 cell death receptor activation and mitochondrial impairment in oxaliplatin-induced apoptosis and neuronal injury: cellular mechanisms and approach. PLoS One 8:e66830. doi: 10.1371\/journal.pone.0066830","journal-title":"PLoS One"},{"key":"405_CR45","doi-asserted-by":"publisher","first-page":"13525","DOI":"10.1073\/pnas.0705924104","volume":"104","author":"CR McNamara","year":"2007","unstructured":"McNamara CR, Mandel-Brehm J, Bautista DM et al (2007) TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci 104:13525\u201313530. doi: 10.1073\/pnas.0705924104","journal-title":"Proc Natl Acad Sci"},{"key":"405_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ejphar.2015.10.005","volume":"766","author":"L Micheli","year":"2015","unstructured":"Micheli L, Di Cesare Mannelli L, Rizzi A et al (2015) Intrathecal administration of nociceptin\/orphanin FQ receptor agonists in rats: a strategy to relieve chemotherapy-induced neuropathic hypersensitivity. Eur J Pharmacol 766:155\u2013162. doi: 10.1016\/j.ejphar.2015.10.005","journal-title":"Eur J Pharmacol"},{"key":"405_CR47","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1742-7843.2011.00746.x","volume":"109","author":"HF Miranda","year":"2011","unstructured":"Miranda HF, Noriega V, Olavarria L et al (2011) Antinociception and Anti-Inflammation Induced by Simvastatin in Algesiometric Assays in Mice. Basic Clin Pharmacol Toxicol 109:438\u2013442. doi: 10.1111\/j.1742-7843.2011.00746.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"405_CR48","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.pain.2011.02.051","volume":"152","author":"R Nassini","year":"2011","unstructured":"Nassini R, Gees M, Harrison S et al (2011) Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation. Pain 152:1621\u20131631. doi: 10.1016\/j.pain.2011.02.051","journal-title":"Pain"},{"key":"405_CR49","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1111\/bph.13129","volume":"172","author":"R Nassini","year":"2015","unstructured":"Nassini R, Fusi C, Materazzi S et al (2015) The TRPA1 channel mediates the analgesic action of dipyrone and pyrazolone derivatives. Br J Pharmacol 172:3397\u20133411. doi: 10.1111\/bph.13129","journal-title":"Br J Pharmacol"},{"key":"405_CR50","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.neuroscience.2016.07.029","volume":"333","author":"M Ohsawa","year":"2016","unstructured":"Ohsawa M, Ishikura K, Mutoh J, Hisa H (2016) Involvement of inhibition of RhoA\/Rho kinase signaling in simvastatin-induced amelioration of neuropathic pain. Neuroscience 333:204\u2013213. doi: 10.1016\/j.neuroscience.2016.07.029","journal-title":"Neuroscience"},{"key":"405_CR51","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13750","author":"LM Plein","year":"2017","unstructured":"Plein LM, Rittner HL (2017) Opioids and the immune system\u2014friend or foe. Br JPharmacol. doi: 10.1111\/bph.13750","journal-title":"Br JPharmacol"},{"issue":"9","key":"405_CR52","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1007\/s11064-0161958-1","volume":"41","author":"Y Qiu","year":"2016","unstructured":"Qiu Y, Chen WY, Wang ZY et al (2016) Simvastatin attenuates neuropathic pain by inhibiting the RhoA\/LIMK\/Cofilin pathway. Neurochem Res 41(9):2457\u20132469. doi: 10.1007\/s11064-0161958-1","journal-title":"Neurochem Res"},{"key":"405_CR53","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/jcpt.12461","volume":"42","author":"RB Raffa","year":"2017","unstructured":"Raffa RB, Burdge G, Gambrah J et al (2017) Cebranopadol: novel dual opioid\/NOP receptor agonist analgesic. J Clin Pharm Ther 42:8\u201317. doi: 10.1111\/jcpt.12461","journal-title":"J Clin Pharm Ther"},{"key":"405_CR54","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.pain.2006.03.021","volume":"124","author":"A Rizzi","year":"2006","unstructured":"Rizzi A, Nazzaro C, Marzola GG et al (2006) Endogenous nociceptin\/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: pharmacological and genetic evidences. Pain 124:100\u2013108. doi: 10.1016\/j.pain.2006.03.021","journal-title":"Pain"},{"key":"405_CR55","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/j.peptides.2005.05.022","volume":"26","author":"T Sakurada","year":"2005","unstructured":"Sakurada T, Komatsu T, Moriyama T et al (2005) Effects of intraplantar injections of nociceptin and its N-terminal fragments on nociceptive and desensitized responses induced by capsaicin in mice. Peptides 26:2505\u20132512. doi: 10.1016\/j.peptides.2005.05.022","journal-title":"Peptides"},{"key":"405_CR56","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1631\/jzus.B1400189","volume":"16","author":"K Sa\u0142at","year":"2015","unstructured":"Sa\u0142at K, Filipek B (2015) Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice. J Zhejiang Univ B 16:167\u2013178. doi: 10.1631\/jzus.B1400189","journal-title":"J Zhejiang Univ B"},{"key":"405_CR57","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1734-1140(09)70136-7","volume":"61","author":"K Sa\u0142at","year":"2009","unstructured":"Sa\u0142at K, Filipek B, Wi\u0229ckowski K, Malawska B (2009) Analgesic activity of 3-mono-substituted derivatives of dihydrofuran-2-one in experimental rodent models of pain. Pharmacol Rep 61:807\u2013818. doi: 10.1016\/S1734-1140(09)70136-7","journal-title":"Pharmacol Rep"},{"key":"405_CR58","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/FBP.0b013e3283566042","volume":"23","author":"K Sa\u0142at","year":"2012","unstructured":"Sa\u0142at K, Librowski T, Moniczewski A et al (2012) Analgesic, antioedematous and antioxidant activity of \u03b3-butyrolactone derivatives in rodents. Behav Pharmacol 23:407\u2013416. doi: 10.1097\/FBP.0b013e3283566042","journal-title":"Behav Pharmacol"},{"key":"405_CR59","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.pbb.2013.06.013","volume":"110","author":"K Sa\u0142at","year":"2013","unstructured":"Sa\u0142at K, Kulig K, Gajda J et al (2013a) Evaluation of anxiolytic-like, anticonvulsant, antidepressant-like and antinociceptive properties of new 2-substituted 4-hydroxybutanamides with affinity for GABA transporters in mice. Pharmacol Biochem Behav 110:145\u2013153. doi: 10.1016\/j.pbb.2013.06.013","journal-title":"Pharmacol Biochem Behav"},{"key":"405_CR60","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.2174\/09298673113209990107","volume":"20","author":"K Sa\u0142at","year":"2013","unstructured":"Sa\u0142at K, Moniczewski A, Librowski T (2013b) Transient receptor potential channels\u2014emerging novel drug targets for the treatment of pain. Curr Med Chem 20:1409\u20131436. doi: 10.2174\/09298673113209990107","journal-title":"Curr Med Chem"},{"key":"405_CR61","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pbb.2014.03.025","volume":"122","author":"K Sa\u0142at","year":"2014","unstructured":"Sa\u0142at K, Cios A, Wyska E et al (2014) Antiallodynic and antihyperalgesic activity of 3-[4-(3-trifluoromethyl- phenyl)-piperazin-1-yl]-dihydrofuran-2-one compared to pregabalin in chemotherapy-induced neuropathic pain in mice. Pharmacol Biochem Behav 122:173\u2013181. doi: 10.1016\/j.pbb.2014.03.025","journal-title":"Pharmacol Biochem Behav"},{"key":"405_CR62","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1517\/13543784.2015.1036985","volume":"24","author":"K Sa\u0142at","year":"2015","unstructured":"Sa\u0142at K, Jakubowska A, Kulig K (2015a) Cebranopadol: a first-in-class potent analgesic agent with agonistic activity at nociceptin\/orphanin FQ and opioid receptors. Expert Opin Investig Drugs 24:837\u2013844. doi: 10.1517\/13543784.2015.1036985","journal-title":"Expert Opin Investig Drugs"},{"key":"405_CR63","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.pharep.2014.11.003","volume":"67","author":"K Sa\u0142at","year":"2015","unstructured":"Sa\u0142at K, Podkowa A, Kowalczyk P et al (2015b) Anticonvulsant active inhibitor of GABA transporter subtype 1, tiagabine, with activity in mouse models of anxiety, pain and depression. Pharmacol Rep 67:465\u2013472. doi: 10.1016\/j.pharep.2014.11.003","journal-title":"Pharmacol Rep"},{"key":"405_CR64","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1111\/bph.12744","volume":"171","author":"W Schr\u00f6der","year":"2014","unstructured":"Schr\u00f6der W, Lambert DG, Ko MC, Koch T (2014) Functional plasticity of the N\/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists. Br J Pharmacol 171:3777\u20133800. doi: 10.1111\/bph.12744","journal-title":"Br J Pharmacol"},{"issue":"3","key":"405_CR65","doi-asserted-by":"crossref","first-page":"249","DOI":"10.36076\/ppj.2011\/14\/249","volume":"14","author":"N Sehgal","year":"2011","unstructured":"Sehgal N, Smith HS, Manchikanti L (2011) Peripherally acting opioids and clinical implications for pain control. Pain Physician 14(3):249\u2013258","journal-title":"Pain Physician"},{"key":"405_CR66","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/sj.bjp.0702068","volume":"125","author":"S Shah","year":"1998","unstructured":"Shah S, Page CP, Spina D (1998) Nociceptin inhibits non-adrenergic non-cholinergic contraction in guinea-pig airway. Br J Pharmacol 125:510\u2013516. doi: 10.1038\/sj.bjp.0702068","journal-title":"Br J Pharmacol"},{"key":"405_CR67","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.pain.2011.01.006","volume":"152","author":"XQ Shi","year":"2011","unstructured":"Shi XQ, Lim TKY, Lee S et al (2011) Statins alleviate experimental nerve injury-induced neuropathic pain. Pain 152:1033\u20131043. doi: 10.1016\/j.pain.2011.01.006","journal-title":"Pain"},{"key":"405_CR68","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/bph.13416","volume":"173","author":"SR Singh","year":"2016","unstructured":"Singh SR, Sullo N, Matteis M et al (2016) Nociceptin\/orphanin FQ (N\/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma. Br J Pharmacol 173:1286\u20131301. doi: 10.1111\/bph.13416","journal-title":"Br J Pharmacol"},{"key":"405_CR69","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2174\/13894501113149990174","volume":"14","author":"M Sobczak","year":"2013","unstructured":"Sobczak M, Salaga M, Storr M, Fichna J (2013) Nociceptin\/orphanin FQ (NOP) receptors as novel potential target in the treatment of gastrointestinal diseases. Curr Drug Targets 14:1203\u20131209","journal-title":"Curr Drug Targets"},{"key":"405_CR70","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.peptides.2014.08.005","volume":"60","author":"M Sobczak","year":"2014","unstructured":"Sobczak M, Pilarczyk A, Jonakowski M et al (2014) Anti-inflammatory and antinociceptive action of the dimeric enkephalin peptide biphalin in the mouse model of colitis: new potential treatment of abdominal pain associated with inflammatory bowel diseases. Peptides 60:102\u2013106. doi: 10.1016\/j.peptides.2014.08.005","journal-title":"Peptides"},{"key":"405_CR71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1124\/jpet.113.203984","volume":"346","author":"DD Sukhtankar","year":"2013","unstructured":"Sukhtankar DD, Zaveri NT, Husbands SM, Ko M-C (2013) Effects of spinally administered bifunctional nociceptin\/orphanin fq peptide receptor\/-Opioid receptor ligands in mouse models of neuropathic and inflammatory pain. J Pharmacol Exp Ther 346:11\u201322. doi: 10.1124\/jpet.113.203984","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"405_CR72","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/HYPERTENSIONAHA.113.02573","volume":"63","author":"J Sun","year":"2014","unstructured":"Sun J, Yang T, Wang P et al (2014) Activation of cold-sensing transient receptor potential melastatin subtype 8 antagonizes vasoconstriction and hypertension through attenuating RhoA\/Rho kinase pathway. Hypertension 63(6):1354\u20131363. doi: 10.1161\/HYPERTENSIONAHA.113.02573","journal-title":"Hypertension"},{"key":"405_CR73","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.npep.2015.03.006","volume":"52","author":"J Tajti","year":"2015","unstructured":"Tajti J, Szok D, Majlath Z et al (2015) Migraine and neuropeptides. Neuropeptides 52:19\u201330. doi: 10.1016\/j.npep.2015.03.006","journal-title":"Neuropeptides"},{"key":"405_CR74","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/sj.bjp.0700942","volume":"120","author":"J-H Tian","year":"1997","unstructured":"Tian J-H, Xu W, Fang Y et al (1997) Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat. Br J Pharmacol 120:676\u2013680. doi: 10.1038\/sj.bjp.0700942","journal-title":"Br J Pharmacol"},{"key":"405_CR75","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-T","volume":"51","author":"A Tj\u00f8lsen","year":"1992","unstructured":"Tj\u00f8lsen A, Berge O-G, Hunskaar S et al (1992) The formalin test: an evaluation of the method. Pain 51:5\u201317. doi: 10.1016\/0304-3959(92)90003-T","journal-title":"Pain"},{"key":"405_CR76","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.pain.2012.12.022","volume":"154","author":"N Torrance","year":"2013","unstructured":"Torrance N, Ferguson JA, Afolabi E et al (2013) Neuropathic pain in the community: more under-treated than refractory? Pain 154:690\u2013699. doi: 10.1016\/j.pain.2012.12.022","journal-title":"Pain"},{"key":"405_CR77","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12558","author":"TM Tzschentke","year":"2017","unstructured":"Tzschentke TM, Linz K, Frosch S, Christoph T (2017) Antihyperalgesic, antiallodynic, and antinociceptive effects of cebranopadol, a novel potent nociceptin\/orphanin FQ and opioid receptor agonist, after peripheral and central administration in rodent models of neuropathic pain. Pain Pract. doi: 10.1111\/papr.12558","journal-title":"Pain Pract"},{"key":"405_CR78","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1177\/0269881117691456","volume":"31","author":"G Vitale","year":"2017","unstructured":"Vitale G, Filaferro M, Micioni Di Bonaventura MV et al (2017) Effects of [Nphe 1, Arg 14, Lys 15] N\/OFQ-NH 2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress. J Psychopharmacol 31:691\u2013703. doi: 10.1177\/0269881117691456","journal-title":"J Psychopharmacol"},{"key":"405_CR79","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/978-3-662-03333-3_8","volume-title":"Drug discovery and evaluation","author":"HG Vogel","year":"1997","unstructured":"Vogel HG, Vogel WH (1997) Analgesic, anti-inflammatory, and antipyretic activity. Drug discovery and evaluation. Springer, Berlin, pp 360\u2013420"},{"key":"405_CR80","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0167-0115(98)00161-X","volume":"79","author":"JL Wang","year":"1999","unstructured":"Wang JL, Bin ZhuC, Cao XD, Wu GC (1999) Distinct effect of intracerebroventricular and intrathecal injections of nociceptin\/orphanin FQ in the rat formalin test. Regul Pept 79:159\u2013163. doi: 10.1016\/S0167-0115(98)00161-X","journal-title":"Regul Pept"},{"issue":"4","key":"405_CR81","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.3892\/or.2015.4192","volume":"34","author":"L Wang","year":"2015","unstructured":"Wang L, Peng J, Huang H et al (2015) Simvastatin protects Sertoli cells against cisplatin cytotoxicity through enhanced gap junction intercellular communication. Oncol Rep 34(4):2133\u20132141. doi: 10.3892\/or.2015.4192","journal-title":"Oncol Rep"},{"key":"405_CR82","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00709-015-0821-6","volume":"253","author":"M Waseem","year":"2016","unstructured":"Waseem M, Parvez S (2016) Neuroprotective activities of curcumin and quercetin with potential relevance to mitochondrial dysfunction induced by oxaliplatin. Protoplasma 253:417\u2013430. doi: 10.1007\/s00709-015-0821-6","journal-title":"Protoplasma"},{"key":"405_CR83","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pharmthera.2013.10.011","volume":"141","author":"JM Witkin","year":"2014","unstructured":"Witkin JM, Statnick MA, Rorick-Kehn LM et al (2014) The biology of Nociceptin\/Orphanin FQ (N\/OFQ) related to obesity, stress, anxiety, mood, and drug dependence. Pharmacol Ther 141:283\u2013299","journal-title":"Pharmacol Ther"},{"key":"405_CR84","first-page":"2092","volume":"7","author":"XJ Xu","year":"1996","unstructured":"Xu XJ, Hao JX, Wiesenfeld-Hallin Z (1996) Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ\/nociceptin in the rat. NeuroReport 7:2092\u20132094","journal-title":"NeuroReport"},{"key":"405_CR85","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0306-4522(97)00166-8","volume":"81","author":"T Yamamoto","year":"1997","unstructured":"Yamamoto T, Nozaki-Taguchi N, Kimura S (1997a) Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like receptor agonist, in the rat formalin test. Neuroscience 81:249\u2013254. doi: 10.1016\/S0306-4522(97)00166-8","journal-title":"Neuroscience"},{"key":"405_CR86","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0304-3940(97)13475-9","volume":"224","author":"T Yamamoto","year":"1997","unstructured":"Yamamoto T, Nozaki-Taguchi N, Kimura S (1997b) Effects of intrathecally administered nociceptin, an opioid receptor-like1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat. Neurosci Lett 224:107\u2013110. doi: 10.1016\/S0304-3940(97)13475-9","journal-title":"Neurosci Lett"},{"key":"405_CR87","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1090-3801(98)90047-7","volume":"2","author":"K Yashpal","year":"1998","unstructured":"Yashpal K, Coderre TJ (1998) Influence of formalin concentration on the antinociceptive effects of anti-inflammatory drugs in the formalin test in rats: separate mechanisms underlying the nociceptive effects of low-and high-concentration formalin. Eur J Pain 2:63\u201368. doi: 10.1016\/S1090-3801(98)90047-7","journal-title":"Eur J Pain"},{"key":"405_CR88","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/bph.12701","volume":"172","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Simpson-Durand CD, Standifer KM (2015) Nociceptin\/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder. Br J Pharmacol 172:571\u2013582. doi: 10.1111\/bph.12701","journal-title":"Br J Pharmacol"},{"key":"405_CR89","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1744-8069-8-55","volume":"8","author":"M Zhao","year":"2012","unstructured":"Zhao M, Isami K, Nakamura S et al (2012) Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice. Mol Pain 8:55. doi: 10.1186\/1744-8069-8-55","journal-title":"Mol Pain"},{"key":"405_CR90","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0304-3940(97)00704-0","volume":"235","author":"CB Zhu","year":"1997","unstructured":"Zhu CB, Cao XD, Xu SF, Wu GC (1997) Orphanin FQ potentiates formalin-induced pain behavior and antagonizes morphine analgesia in rats. Neurosci Lett 235:37\u201340. doi: 10.1016\/S0304-3940(97)00704-0","journal-title":"Neurosci Lett"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-017-0405-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-017-0405-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-017-0405-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T18:44:29Z","timestamp":1750963469000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-017-0405-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,25]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["405"],"URL":"https:\/\/doi.org\/10.1007\/s10787-017-0405-5","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,25]]}}}